Chicken Soup for the Soul Entertainment Inc. (CSSEQ) is expected to report for Q2 2024
Amplitech Group Inc. (AMPG) is expected to report for Q2 2024
Adaptimmune Therapeutics plc (ADAP) is expected to report $0 for Q2 2024
Augmedix Inc. (AUGX) is expected to report $-0.12 for Q2 2024
Avalon GloboCare Corp. (ALBT) is expected to report for Q2 2024
Aerovate Therapeutics Inc. (AVTE) is expected to report $-0.76 for Q2 2024
Arq Inc. (ARQ) is expected to report $-0.05 for Q2 2024
Atlantic Lithium Ltd Ord Fully Paid (ALLIF) is expected to report for Q2 2024
Chesapeake Granite Wash Trust Units (CHKR) is expected to report for Q2 2024
Blue Dolphin Energy Co. (BDCO) is expected to report for Q2 2024
Senmiao Technology Limited (AIHS) is expected to report for Q1 2025
Cocrystal Pharma Inc. (COCP) is expected to report $-0.5 for Q2 2024
China Yuchai International Limited (CYD) is expected to report for Q2 2024
Athena Gold Corp (AHNR) is expected to report for Q2 2024
Aditxt Inc. (ADTX) is expected to report for Q2 2024
Adtran Networks SE (ADVOF) is expected to report for quarter end 2024-06-30
Addex Therapeutics Ltd (ADXN) is expected to report $-0.07 for Q2 2024
Blonder Tongue Laboratories Inc. (BDRL) is expected to report for Q2 2024
Centessa Pharmaceuticals plc (CNTA) is expected to report $-0.38 for Q2 2024
CNS Pharmaceuticals Inc. (CNSP) is expected to report for Q2 2024
Atlas Lithium Corporation (ATLX) is expected to report $-0.7 for Q2 2024
AYRO Inc. (AYRO) is expected to report $-1.34 for Q2 2024
ADDvantage Technologies Group Inc. (AEYGQ) is expected to report for quarter end 2024-06-30
bleuacacia ltd (BLEU) is expected to report for quarter end 2024-06-30
CSL Ltd. ADR (CSLLY) is expected to report for Q4 2024
ContraFect Corporation (CFRXQ) is expected to report for Q2 2024
Celularity Inc. (CELU) is expected to report for quarter end 2024-06-30
Astra Space Inc. (ASTR) is expected to report for quarter end 2024-06-30
Blackboxstocks Inc. (BLBX) is expected to report for Q2 2024
Boundless Bio Inc. (BOLD) is expected to report $-0.77 for Q2 2024
Ellington Credit Company Com Shs Ben Int (EARN) is expected to report $0.24 for Q2 2024
BTCS Inc. (BTCS) is expected to report $-0.04 for Q2 2024
Biotricity Inc. (BTCY) is expected to report for Q1 2025
BIO-key International Inc. (BKYI) is expected to report for Q2 2024
Bolt Biotherapeutics Inc. (BOLT) is expected to report $-0.54 for Q2 2024
Biocept Inc. (BIOCQ) is expected to report for quarter end 2024-06-30
Atossa Therapeutics Inc. (ATOS) is expected to report $-0.05 for Q2 2024
BuzzFeed Inc. (BZFD) is expected to report for Q2 2024
bioAffinity Technologies Inc. (BIAF) is expected to report for Q2 2024
AppTech Payments Corp. (APCX) is expected to report for Q2 2024
Ballard Power Systems Inc. (BLDP) is expected to report $-0.13 for Q2 2024
BioStem Technologies Inc (BSEM) is expected to report $0.12 for Q2 2024
CEA Industries Inc. (CEAD) is expected to report for Q2 2024
Beasley Broadcast Group Inc. (BBGI) is expected to report $-0.03 for Q2 2024
Broad Street Realty Inc (BRST) is expected to report for Q2 2024
ASP Isotopes Inc. (ASPI) is expected to report for Q2 2024
Bright Mountain Media Inc (BMTM) is expected to report for Q2 2024
Azul S.A. American Depositary Shares (each representing three preferred shares) (AZUL) is expected to report $-0.75 for Q2 2024
Astria Therapeutics Inc. (ATXS) is expected to report $-0.37 for Q2 2024
Sphere 3D Corp. (ANY) is expected to report $-0.24 for Q2 2024
AST SpaceMobile Inc. (ASTS) is expected to report $-0.19 for Q2 2024
Checkpoint Therapeutics Inc. (CKPT) is expected to report $-0.29 for Q2 2024
Biora Therapeutics Inc. (BIOR) is expected to report $-0.45 for Q2 2024
ABAXX Technologies Inc. (ABXXF) is expected to report for Q2 2024
Addentax Group Corp. (ATXG) is expected to report for quarter end 2024-06-30
Bridger Aerospace Group Holdings Inc Com (BAER) is expected to report for Q2 2024
ABVC BioPharma Inc. (ABVC) is expected to report for Q2 2024
Alset Inc. (AEI) is expected to report for Q2 2024
Clover Leaf Capital Corp. (CLOE) is expected to report for Q2 2024
Chemomab Therapeutics Ltd. (CMMB) is expected to report $-0.2 for Q2 2024
Aspira Women's Health Inc. (AWH) is expected to report $-0.32 for Q2 2024
BioCorRx Inc (BICX) is expected to report for Q2 2024
Bank Hapoalim B.M. ADR (BKHYY) is expected to report for Q2 2024
Carver Bancorp Inc. (CARV) is expected to report for quarter end 2024-06-30
Advanced Oxygen Technologies Inc. (AOXY) is expected to report for Q4 2024
Capstone Companies Inc (CAPC) is expected to report for Q2 2024
Barrick Gold Corporation (BC) (GOLD) is expected to report $0.26 for Q2 2024
CareView Communications Inc (CRVW) is expected to report for Q2 2024
Bullfrog AI Holdings Inc. (BFRG) is expected to report for Q2 2024
American Rebel Holdings Inc. (AREB) is expected to report for Q2 2024
Bluejay Diagnostics Inc. (BJDX) is expected to report for quarter end 2024-06-30
Agape ATP Corporation (ATPC) is expected to report for Q2 2024
Bergio International, Inc. (BRGO) is expected to report for Q2 2024
Annexon Inc. (ANNX) is expected to report $-0.23 for Q2 2024
Scorpius Holdings Inc. (1HB:BE) is expected to report for Q2 2024
Crescent Capital BDC Inc. (CCAP) is expected to report $0.58 for Q2 2024
Charlies Holdings Inc (CHUC) is expected to report for Q2 2024
CREATD INC. (CRTD) is expected to report for quarter end 2024-06-30
AgileThought Inc. (AGILQ) is expected to report for quarter end 2024-06-30
Big Rock Brewery Inc (BRBMF) is expected to report for Q2 2024
Beach Energy Limited ADR (BCHEY) is expected to report for quarter end 2024-06-30
Boston Omaha Corporation Class A (BOC) is expected to report for Q2 2024
Auxly Cannabis Group Inc. (CBWTF) is expected to report for Q2 2024
Bioxytran Inc (BIXT) is expected to report for Q2 2024
A2Z Smart Technologies Corp. (AZ) is expected to report for Q2 2024
Cuentas Inc. (CUEN) is expected to report for Q2 2024
Abacus Life Inc. (ABL) is expected to report $0.13 for Q2 2024
Clean Energy Technologies Inc. (CETY) is expected to report for Q2 2024
Better For You Wellness Inc (BFYW) is expected to report for quarter end 2024-05-31
Cingulate Inc. (CING) is expected to report for Q2 2024
Asset Entities Inc. (ASST) is expected to report for Q2 2024
Bellerophon Therapeutics Inc. (BLPH) is expected to report for quarter end 2024-06-30
DHT Holdings Inc. (DHT) is expected to report $0.28 for Q2 2024
Cara Therapeutics Inc. (CARA) is expected to report $-0.29 for Q2 2024
KE Holdings Inc American Depositary Shares (each representing three Class A) (BEKE) is expected to report $0.11 for Q2 2024
Conrad Industries, Inc. (CNRD) is expected to report for Q2 2024
Clearside Biomedical Inc. (CLSD) is expected to report $-0.14 for Q2 2024
